Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CA125”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04597814
What this trial is testing

The Relationship Between the Tumor Markers and Interstitial Lung Disease

Who this might be right for
the Relationship Between the Tumor Markers and Interstitial Lung Disease Patients
The First Affiliated Hospital of Guangzhou Medical University 13
Not applicableStudy completedNCT03004391
What this trial is testing

Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125

Who this might be right for
Ovarian Cancer
Vejle Hospital 25
Not applicableStudy completedNCT04830332
What this trial is testing

Correlation of Peritoneal Fluid CA-125 Levels With Postoperative Tumor Histology

Who this might be right for
Endometrial Carcinoma
Erdemli State Hospital 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04938583
What this trial is testing

Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer by FIGO StageOvarian Cancer Stage IIIOvarian Cancer Stage IV
CanariaBio Inc. 54
Testing effectiveness (Phase 2)UnknownNCT05311579
What this trial is testing

Niraparib Plus Anlotinib for Recurrent Ovarian Cancer

Who this might be right for
Ovarian CarcinomaSurvival OutcomesAdverse Events+6 more
Lei Li 36
Testing effectiveness (Phase 2)Looking for participantsNCT05080556
What this trial is testing

Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer

Who this might be right for
Ovarian CancerRelapsed Ovarian CancerFallopian Tube Cancer+4 more
University College, London 80
Not applicableUnknownNCT02247323
What this trial is testing

Ovarian Malignancy Incidence in Moderate Risk Women With Low CA 125

Who this might be right for
Ovarian Cancer
Beni-Suef University 200
Not applicableStudy completedNCT00587093
What this trial is testing

Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer

Who this might be right for
Ovarian Cancer
Memorial Sloan Kettering Cancer Center 669
Testing effectiveness (Phase 2)Study completedNCT02289950
What this trial is testing

Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Participants With Low CA125 Platinum-sensitive Ovarian Cancer

Who this might be right for
Platinum-Sensitive Ovarian Cancer in First Relapse
Eisai Inc. 332
Testing effectiveness (Phase 2)Looking for participantsNCT07617753
What this trial is testing

Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Carcinoma+1 more
Beijing Biotech 36
Testing effectiveness (Phase 2)UnknownNCT00305838
What this trial is testing

CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Mount Vernon Cancer Centre at Mount Vernon Hospital 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07295132
What this trial is testing

RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse)

Who this might be right for
Ovarian Cancer RecurrentPlatinum Sensitive Ovarian Cancer
Asan Medical Center 160
Not applicableStudy completedNCT03498924
What this trial is testing

Identification and Characterization of Endometrial Cancer With Specific Tumor Markers in Serum and Endometrial Tissue

Who this might be right for
Endometrial Neoplasm Malignant
Fundación Investigación Sanitaria en León 80
Post-approval studies (Phase 4)Study completedNCT01753154
What this trial is testing

The Effect of Balance PD Solution on the Peritoneal Membrane in Patients on Automated Peritoneal Dialysis

Who this might be right for
Chronic Renal Failure
Fresenius Medical Care Deutschland GmbH 25
Not applicableStudy completedNCT00058032
What this trial is testing

CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women

Who this might be right for
Ovarian Cancer
University College, London 202,638
Testing effectiveness (Phase 2)Looking for participantsNCT07022535
What this trial is testing

Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
The University of Hong Kong 18
Large-scale testing (Phase 3)UnknownNCT04835064
What this trial is testing

Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.

Who this might be right for
Pancreatic Adenocarcinoma
Fudan University 600
Not applicableStudy completedNCT01139957
What this trial is testing

Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer

Who this might be right for
Breast CarcinomaFallopian Tube CarcinomaOvarian Neoplasm+1 more
Gynecologic Oncology Group 1,916
Testing effectiveness (Phase 2)Study completedNCT01111903
What this trial is testing

A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late Relapse

Who this might be right for
Ovarian Cancer Recurrent
ARCAGY/ GINECO GROUP 67
Not applicableUnknownNCT02437760
What this trial is testing

The Prognostic and Predictive Value of the CA-125 Marker in Lung Cancer Monitoring

Who this might be right for
Lung Cancer
E-DA Hospital 200
Next Page